Recent Updates
Recently added Catalysts
RDY Neutral Sentiment Score: 60/100

Dr. Reddy's Laboratories Ltd . 8-2-337, Road No. 3, Banjara Hills Hyderabad - 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.

Key Takeaway: Dr. Reddy's Laboratories Limited has announced a transfer of 17,17,26,540 equity shares, amounting to 20.58% of the company, to family trusts as part of a private family arrangement for succession planning. This transfer was conducted under an exemption provided by a SEBI order. It is notable that the company's management and control remain unchanged as all involved parties are individual promoters or their immediate relatives. The total shareholding of the promoters has not changed as a result of this transfer.

Market Sentiment Analysis

POSITIVE FACTORS

  • The transfer of shares is part of a private family arrangement for succession planning.
  • The overall shareholding of the Promoter and Promoter Group remains unchanged post-transfer.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Disclosure regarding transfer of shares by Promoters to their private family trust
Please note that the Company has received intimation from the Promoters of the Company, that they have settled 17,17,26,540 equity shares of Rs.1/- each aggregating to 20.58% (Pre- Split 3,43,45,308 equity shares of Rs.5/- ) of equity shares through off market transfer on September 17, 2025 in the following manner:
The shares have been acquired by the said Trusts from the Promoters pursuant to exemption provided by SEBI Order dated December 31, 2024 bearing reference number WTM/ASB/CFD/16/2024-25. The said order has been issued under Section 11(1) and 11(2)(h) of the Securities and Exchange Board of India Act, 1992 read with Regulation 11(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Please also note that as a result of aforesaid transfer, there is no change in management and control of the Company. Only individual Promoters or their immediate relatives or lineal descendants are Trustees and Beneficiaries of the Acquirer Trusts.
In this connection, copy of necessary disclosure under Regulation 29(1) and 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as received from Promoters & Promoter group along with the said SEBI order are enclosed.
The shareholding position of Promoter and Promoter Group of the Company, before and post the aforesaid transfer is depicted below for reference:
Particulars Pre - transfer Post - transfer
Number of shares % of shares* Number of shares % of shares*
Satish Reddy Kallam # 8,57,38,125 10.27 1,01,07,505 1.21
VSD Family Trust Nil Nil 75,630,620 9.06
G V Prasad 9,60,95,920 11.51 0 0.00
GVP Family Trust Nil Nil 9,60,95,920 11.51
Late Samrajyam Reddy Kallam - - - -
Kallam Satish Reddy HUF 2,76,18,385 3.31 2,76,18,385 3.31
Deepti Reddy Kallam 25,700 0.00 25,700 0.00
K Shravya Reddy 0 0.00 0 0.00
K Vishal Reddy 0 0.00 0 0.00
Gunupati Venkateswara Prasad HUF 1,27,17,090 1.52 1,27,17,090 1.52
Anuradha Gunupati 46,025 0.01 46,025 0.01
Sharathchandra Reddy Gunupati 13,000 0.00 13,000 0.00
Gunupati Mallika Reddy 25,695 0.00 25,695 0.00
G Vani Sanjana Reddy 25,700 0.00 25,700 0.00
VSD Holdings & Advisory LLP 0 0.00 0 0.00
APS Trust 0 0.00 0 0.00
Total 22,23,05,640 26.64 22,23,05,640 26.64
*Total share capital/ voting rights has be taken as per the latest shareholding pattern filing done by the company on the Stock Exchange under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
#Inclusive of shares received by way of transmission on March 18, 2025 and intimated to Stock Exchanges on March 20, 2025.
The aggregate holding of Promoter & Promoter group before and after the said transfer has remained the same.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR
BSE Limited (Scrip Code: 500124)
National Stock Exchange of India Limited (Scrip Code: DRREDDY)
New York Stock Exchange Inc. (NYSE)
The Company Secretary,
Dr. Reddy's Laboratories Limited
8-2-337, Road No-3, Banjara Hills,
Hyderabad-500034, Telangana, India.
Sub: Disclosure under Regulation 29(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Please find attached herewith the disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in connection with the acquisition of 17,17,26,540 equity shares of Rs.1/- each aggregating to 20.58% (Pre- Split 3,43,45,308 equity shares of Rs.5/-) of Dr. Reddy's Laboratories Limited being the Target Company ("TC") through an off-market transfer on September 17, 2025 in the following manner:
This transfer is only a private family arrangement, for smooth succession planning of the family and to streamline the family's assets and businesses. The shares have been acquired by the said Trusts from the Promoters pursuant to exemption provided in SEBI Order dated December 31, 2024 bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited".
There is no change in the total Shareholding of the Promoters post such transfer of shares of the Target Company.
You are requested to take the same on records.
(Satish Reddy Kallam) Trustee of VSD Family Trust (Acquirer) (G V Prasad) Trustee of GVP Family Trust (Acquirer)
(Deepti Reddy Kallam) Trustee of VSD Family Trust (Acquirer) (Anuradha Gunupati) Trustee of GVP Family Trust (Acquirer)
Format for disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
Part-A - Details of the Acquisition
Name of the Target Company (TC) Dr. Reddy's Laboratories Limited
Name(s) of the acquirers and Persons Acting in Concert (PAC) with the acquirer Acquirers 1. VSD Family Trust 2. GVP Family Trust Names of the PAC(s): 1. Satish Reddy Kallam 2. G V Prasad 3. Late Samrajyam Reddy Kallam 4. Deepti Reddy Kallam 5. K Shravya Reddy 6. K Vishal Reddy 7. Anuradha Gunupati 8. Sharathchandra Reddy Gunupati 9. Gunpati Mallika Reddy 10. G Vani Sanjana Reddy 11. Kallam Satish Reddy HUF 12. Gunupati Venkateswara Prasad HUF 13. APS Trust 14. VSD Holdings & Advisory LLP
Whether the acquirer belongs to Promoter / Promoter group Yes. Pursuant to SEBI Order dated December 31, 2024 bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited", the disclosure is made upon transfer of shares by Individual Promoters of the Target Company, namely Satish Reddy Kallam and G V Prasad respectively, to the following, being the Acquirer(s)/ transferee(s) in each case: 1. VSD Family Trust 2. GVP Family Trust
Name(s) of the Stock Exchange(s) where the shares of TC are Listed The equity shares of the Company are listed on the BSE Ltd and NSE Ltd and ADRs underlying equity shares are listed on NSE(IFSC) and NYSE.
Details of the acquisition as follows Number % w.r.t. total share/voting capital wherever applicable(*) % w.r.t. total diluted share/voting capital of the TC (**)
Before the acquisition under consideration, holding of acquirer along with PACs of:
a. Shares carrying voting rights
Acquirers
(i) VSD Family Trust 0 0.00 0.00
(ii) GVP Family Trust 0 0.00 0.00
Persons Acting in Concert
(i) Gunupati Venkateswara Prasad HUF 1,27,17,090 1.52 1.51
(ii) Anuradha Gunupati 46,025 0.01 0.01
(iii) Late Samrajyam Reddy Kallam 1 - - -
(iv) Kallam Satish Reddy HUF 2,76,18,385 3.31 3.29
(v) Sharathchandra Reddy Gunupati 13,000 0.00 0.00
(vi) Deepti Reddy Kallam 25,700 0.00 0.00
(vii) G Vani Sanjana Reddy 25,700 0.00 0.00
(viii) Gunupati Mallika Reddy 25,695 0.00 0.00
(ix) K Shravya Reddy 0 0.00 0.00
(x) K Vishal Reddy 0 0.00 0.00
(xi) VSD Holdings & Advisory LLP 0 0.00 0.00
(xii) APS Trust 0 0.00 0.00
(xiii) Satish Reddy Kallam 2 8,57,38,125 10.27 10.20
(xiv) G V Prasad 9,60,95,920 11.51 11.43
b. Shares in the nature of encumbrance (pledge/ lien/ non disposal undertaking/ others) - - -
c. Voting rights (VR) otherwise than by shares - - -
d. Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) - - -
e. Total (a+b+c+d) 22,23,05,640 26.64 26.45
Details of acquisition
a. Shares carrying voting rights acquired
1. VSD Family Trust 7,56,30,620 9.06 9.00
2. GVP Family Trust 9,60,95,920 11.51 11.43
b. VRs acquired otherwise than by equity shares - - -
c. Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired - - -
d. Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) - - -
e. Total (a+b+c+/-d) 17,17,26,540 20.57 20.43
After the acquisition, holding of acquirer along with PACs of:
a. Shares carrying voting rights:
Acquirers
(i) VSD Family Trust 7,56,30,620 9.06 9.00
(ii) GVP Family Trust 9,60,95,920 11.51 11.43
Persons Acting in Concert
(i) Gunupati Venkateswara Prasad HUF 1,27,17,090 1.52 1.51
(ii) Anuradha Gunupati 46,025 0.01 0.01
(iii) Late Samrajyam Reddy Kallam 1 - - -
(iv) Kallam Satish Reddy HUF 2,76,18,385 3.31 3.29
(v) Sharathchandra Reddy Gunupati 13,000 0.00 0.00
(vi) Deepti Reddy Kallam 25,700 0.00 0.00
(vii) G Vani Sanjana Reddy 25,700 0.00 0.00
(viii) Gunupati Mallika Reddy 25,695 0.00 0.00
(ix) K Shravya Reddy 0 0.00 0.00
(x) K Vishal Reddy 0 0.00 0.00
(xi) VSD Holdings & Advisory LLP 0 0.00 0.00
(xii) APS Trust 0 0.00 0.00
(xiii) Satish Reddy Kallam 2 1,01,07,505 1.21 1.20
(xiv) G V Prasad - - -
b. VRs otherwise than by equity shares - - -
c. Warrants/convertible securities /any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition - - -
d. Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) - - -
e. Total (a+b+c+d) 22,23,05,640 26.64 26.45
Mode of acquisition ( e.g. open market / public issue / rights issue / preferential allotment / inter-se transfer / encumbrance, etc .) Acquired Equity Shares pursuant to SEBI Order dated December 31, 2024 bearing reference number bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited" in the following manner: 1. Transfer of 7,56,30,620 (9.06%) equity shares by Satish Reddy Kallam to VSD Family Trust.
2. Transfer of 9,60,95,920 (11.51%) equity shares by G V Prasad to GVP Family Trust.
Salient features of the securities acquired including time till redemption, ratio at which it can be converted into equity shares, etc. Equity Shares carrying voting rights
Date of acquisition of / date of receipt of intimation of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC. September 17, 2025
Equity share capital / total voting capital of the TC before the said acquisition* 83,45,81,775 shares of Rs. 1/- each aggregating INR 83,45,81,775/-
Equity share capital/ total voting capital of the TC after the said acquisition* 83,45,81,775 shares of Rs. 1/- each aggregating INR 83,45,81,775/-
Total diluted share/voting capital of the TC after the said acquisition* 84,05,21,370 shares of Rs. 1/- each aggregating INR 84,05,21,370/-
* Total share capital/ voting capital has be taken as per the latest shareholding pattern filing done by the company on the Stock Exchange under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Signature of the Acquirer / Authorised Signatory
(Satish Reddy Kallam) Trustee of VSD Family Trust (Acquirer) (G V Prasad) Trustee of GVP Family Trust (Acquirer)
(Deepti Reddy Kallam) Trustee of VSD Family Trust (Acquirer) (Anuradha Gunupati) Trustee of GVP Family Trust (Acquirer)
Date: September 18, 2025
BSE Limited (Scrip Code: 500124)
National Stock Exchange of India Limited (Scrip Code: DRREDDY)
New York Stock Exchange Inc. (NYSE)
The Company Secretary,
Dr. Reddy's Laboratories Limited
8-2-337, Road No-3, Banjara Hills,
Hyderabad-500034, Telangana, India.
Sub: Disclosure under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Please find attached herewith the disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in connection with the transfer of 17,17,26,540 equity shares of Rs.1/- each aggregating to 20.58% (Pre- Split 3,43,45,308 equity shares of Rs.5/-) of Dr. Reddy's Laboratories Limited being the Target Company ("TC") through an off-market transfer on September 17, 2025 in the following manner:
This transfer is only a private family arrangement, for smooth succession planning of the family and to streamline the family's assets and businesses. The shares have been acquired by the said Trusts from the Promoters, pursuant to exemption provided in SEBI Order dated December 31, 2024 bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited".
There is no change in the total Shareholding of the Promoters post such transfer of shares of Target Company.
You are requested to take the same on records.
Thanking You.
(Satish Reddy Kallam) (G V Prasad)
Promoter of Dr. Reddy's Laboratories Limited (Transferor) Promoter of Dr. Limited Reddy's Laboratories (Transferor)
Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
Name of the Target Company (TC) Dr. Reddy's Laboratories Limited
Name(s) of the acquirers and Persons Acting in Concert (PAC) with the acquirer Acquirers 1. VSD Family Trust 2. GVP Family Trust
Names of the PAC(s): Promoters: 1. Satish Reddy Kallam 2. G V Prasad 3. Late Samrajyam Reddy Kallam 4. Kallam Deepti Reddy 5. K Shravya Reddy 6. K Vishal Reddy 7. Anuradha Gunupati 8. Sharathchandra Reddy Gunupati 9. Gunupati Mallika Reddy 10. G Vani Sanjana Reddy 11. Kallam Satish Reddy HUF 12. Gunupati Venkateswara Prasad HUF 13. APS Trust 14. VSD Holdings & Advisory LLP
Whether the acquirer belongs to Promoter / Promoter group Yes.
Pursuant to SEBI Order dated December 31, 2024 bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited", the disclosure is made upon transfer of shares by Individual Promoters of the Target Company, namely Satish Reddy Kallam and G V Prasad respectively to the following, being the Acquirer(s)/ transferee(s) in each case:
1. VSD Family Trust 2. GVP Family Trust
Name(s) of the Stock Exchange(s) where the shares of TC are Listed The equity shares of the Company are listed on the BSE Ltd and NSE Ltd and ADRs underlying equity shares are listed on NSE(IFSC) and NYSE.
Details of the acquisition as follows Number % w.r.t. total share/voting capital wherever applicable(*) % w.r.t. total diluted share/voting capital of the TC (**)
Before the acquisition under consideration, holding of acquirer along with PACs of:
a. Shares carrying voting rights
Acquirers
(i) VSD Family Trust 0 0.00 0.00
(ii) GVP Family Trust 0 0.00 0.00
Persons Acting in Concert
(i) Gunupati Venkateswara Prasad HUF 1,27,17,090 1.52 1.51
(ii) Anuradha Gunupati 46,025 0.01 0.01
(iii) Late Samrajyam Reddy Kallam 1 - - -
(iv) Kallam Satish Reddy HUF 2,76,18,385 3.31 3.29
(v) Sharathchandra Reddy Gunupati 13,000 0.00 0.00
(vi) Deepti Reddy Kallam 25,700 0.00 0.00
(vii) G Vani Sanjana Reddy 25,700 0.00 0.00
(viii) Gunupati Mallika Reddy 25,695 0.00 0.00
(ix) K Shravya Reddy 0 0.00 0.00
(x) K Vishal Reddy 0 0.00 0.00
(xi) VSD Holdings & Advisory LLP 0 0.00 0.00
(xii) APS Trust 0 0.00 0.00
(xiii) Satish Reddy Kallam 2 8,57,38,125 10.27 10.20
(xiv) G V Prasad 9,60,95,920 11.51 11.43
b. Shares in the nature of encumbrance (pledge/ lien/ non disposal undertaking/ others) - - -
c. Voting rights (VR) otherwise than by shares - - -
d. Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) - - -
e. Total (a+b+c+d) 22,23,05,640 26.64 26.45
Details of acquisition
a. Shares carrying voting rights acquired
1. VSD Family Trust 7,56,30,620 9.06 9.00
2. GVP Family Trust 9,60,95,920 11.51 11.43
b. VRs acquired otherwise than by equity shares - - -
c. Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired - - -
d. Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) - - -
e. Total (a+b+c+/-d) 17,17,26,540 20.57 20.43
After the acquisition, holding of acquirer along with PACs of:
a. Shares carrying voting rights:
Acquirers
(i) VSD Family Trust 7,56,30,620 9.06 9.00
(ii) GVP Family Trust 9,60,95,920 11.51 11.43
Persons Acting in Concert
(i) Gunupati Venkateswara Prasad HUF 1,27,17,090 1.52 1.51
(ii) Anuradha Gunupati 46,025 0.01 0.01
(iii) Late Samrajyam Reddy Kallam 1 - - -
(iv) Kallam Satish Reddy HUF 2,76,18,385 3.31 3.29
(v) Sharathchandra Reddy Gunupati 13,000 0.00 0.00
(vi) Deepti Reddy Kallam 25,700 0.00 0.00
(vii) G Vani Sanjana Reddy 25,700 0.00 0.00
(viii) Gunupati Mallika Reddy 25,695 0.00 0.00
(ix) K Shravya Reddy 0 0.00 0.00
(x) K Vishal Reddy 0 0.00 0.00
(xi) VSD Holdings & Advisory LLP 0 0.00 0.00
(xii) APS Trust 0 0.00 0.00
(xiii) Satish Reddy Kallam 2 1,01,07,505 1.21 1.20
(xiv) G V Prasad - - -
b. VRs otherwise than by equity shares
c. Warrants/convertible securities /any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition
d. Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others)
e. Total (a+b+c+d) 22,23,05,640 26.64 26.45
Mode of acquisition ( e.g. open market / public issue / rights issue / preferential allotment / inter-se transfer / encumbrance, etc .) Transfer of equity Shares pursuant to SEBI Order dated December 31, 2024 bearing reference number bearing reference number WTM/ASB/CFD/16/2024-25 in the matter of "Dr. Reddy's Laboratories Limited" in the following manner:
1. Transfer of 7,56,30,620 equity shares of Rs.1/- each (9.06%) (Pre-Split 1,51,26,124 equity shares of Rs.5/- ) by Mr. Satish Reddy Kallam to VSD Family Trust
2. Transfer of 9,60,95,920 equity shares of Rs.1/-each (11.51%) (Pre-Split
1,92,19,184 equity shares of Rs.5/- ) by Mr. G V Prasad to the GVP Family Trust
Salient features of the securities acquired including time till redemption, ratio at which it can be converted into equity shares, etc. Equity Shares carrying voting rights
Date of acquisition of / date of receipt of intimation of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC. September 17, 2025
Equity share capital / total voting capital of the TC before the said acquisition* 83,45,81,775 shares of Rs. 1/- each aggregating INR 83,45,81,775/-
Equity share capital/ total voting capital of the TC after the said acquisition* 83,45,81,775 shares of Rs. 1/- each aggregating INR 83,45,81,775/-
Total diluted share/voting capital of the TC after the said acquisition* 84,05,21,370 shares of Rs. 1/- each aggregating INR 84,05,21,370/-
* Total share capital/ voting capital has be taken as per the latest shareholding pattern filing done by the company on the Stock Exchange under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Date: September 18, 2025

Frequently Asked Questions

What is the recent share transfer by Dr. Reddy's Promoters?

Promoters transferred 17,17,26,540 shares, equating to 20.58%, to family trusts.

Were there any management changes after the share transfer?

No, the transfer did not result in any change in the management or control.

What is the purpose of the share transfer?

The transfer aims to facilitate smooth succession planning within the family.

How were the shares acquired by the trusts?

The trusts acquired shares under a SEBI exemption order dated December 31, 2024.

What was the total shareholding of Promoters after the transfer?

The total holding of the Promoter group remained unchanged at 26.64%.

Last updated: Sep 18, 2025